Transunion

Market Movers (8-K)

See all →
NYSE
TransUnion reported strong second quarter 2026 financial results, exceeding revenue, Adjusted EBITDA, and Adjusted Diluted Earnings Per Share guidance, and raised its full-year outlook.
Better than expected
NYSE
TransUnion announced robust first-quarter 2026 financial results, exceeding guidance for revenue, Adjusted EBITDA, and Adjusted Diluted Earnings Per Share, and raised its full-year 2026 financial outlook.
Better than expected
NYSE
TransUnion reported strong fourth-quarter and full-year 2025 results, exceeding financial guidance, increasing its dividend, and expanding its revolving credit facility to $1 billion.
Capital raise
Better than expected
NYSE
TransUnion's Board of Directors expanded to 12 members with the appointment of Sayan Chakraborty and Charlotte Yarkoni, bringing deep expertise in product, technology, AI, and cloud innovation.
Better than expected
NYSE
TransUnion announced strong third-quarter 2025 financial results, surpassing all key metrics and raising its full-year guidance, driven by accelerated growth in U.S. Financial Services and Emerging Verticals.
Capital raise
Better than expected
NYSE
TransUnion reported second quarter 2025 financial results that exceeded guidance across all key metrics, driven by strong growth in U.S. Financial Services and International markets, leading the company to raise its full-year 2025 financial guidance.
Better than expected

Quarterly Earnings (10-Q)

See all →
NYSE
TransUnion reported a 14.9% increase in revenue for Q2 2026, reaching $1.31 billion, largely driven by strategic acquisitions and growth in its U.S. Markets and International segments.
NYSE
TransUnion reports a 13.7% increase in revenue for Q1 2026, largely driven by the acquisition of Trans Union de Mexico and growth across its U.S. Markets and International segments.
Better than expected
NYSE
TransUnion reported significant revenue and earnings growth for the third quarter and first nine months of 2025, driven by strong performance in U.S. Financial Services and International segments, alongside an increased share repurchase authorization.
Better than expected
NYSE
TransUnion announced robust financial results for the second quarter and first half of 2025, with significant revenue and net income growth, bolstered by strong performance in its U.S. Markets segment and the strategic acquisition of Monevo Limited.
Better than expected
NYSE
TransUnion's Q1 2025 results show revenue growth and increased profitability, driven by U.S. Markets performance and the ongoing transformation plan.
Better than expected
NYSE
TransUnion's Q3 2024 results show a 12% revenue increase year-over-year, driven by growth in both U.S. and international markets, while the company continues its transformation plan.
Better than expected

Annual Reports (10-K)

NYSE
TransUnion reported a robust 9.4% revenue increase and a 60.2% rise in net income for 2025, driven by strategic acquisitions and the completion of its technology transformation plan.
Better than expected
Delay expected
NYSE
TransUnion's 2024 10-K filing highlights its strategic focus on data, technology, and global expansion amidst macroeconomic challenges and regulatory scrutiny.
Worse than expected
NYSE
TransUnion's 2023 annual report highlights a year of strategic investments and operational adjustments amidst a challenging macroeconomic environment.
Worse than expected

Insider Trading (Form 4)

See all →
NYSE
Alicia Brooke Zuiker, EVP, CHRO of TransUnion, sold 8,673 shares of common stock on August 11, 2026 for $78.49 per share.
NYSE
Todd C. Skinner, President, International of TransUnion, sold 950 shares of common stock on August 3, 2026 for $79.96 per share.
NYSE
Steven M Chaouki, President, US Markets of TransUnion, sold 1,000 shares of common stock on August 3, 2026 for $79.96 per share.
NYSE
Mohamed Abdelsadek, EVP, Chief Global Solutions of TransUnion, sold 23,495 shares of common stock on July 28, 2026 for $85.00 per share.
NYSE
TransUnion SVP, Chief Accounting Officer Jennifer A. Williams reported a sale of 972 shares of common stock for $80 per share, executed under a pre-arranged Rule 10b5-1 trading plan.
NYSE
TransUnion EVP, CHRO Alicia Brooke Zuiker reported a transaction involving the sale of 6,899 shares of common stock to cover tax liabilities related to vested restricted stock units.

Proxy Statements (Def-14A)

NYSE
TransUnion announces its 2026 Annual Meeting of Stockholders, highlighting robust 2025 financial and executive compensation performance, alongside key corporate governance updates.
Better than expected
NYSE
TransUnion will hold its annual stockholders meeting virtually on May 7, 2025, to vote on director elections, ratification of PricewaterhouseCoopers LLP, and executive compensation.
NYSE
TransUnion will hold its 2025 Annual Meeting of Stockholders virtually on May 7, 2025, to vote on director elections, ratification of the accounting firm, and executive compensation.
NYSE
TransUnion's upcoming annual meeting on May 2, 2024, will address director elections, auditor ratification, executive compensation, and amendments to stock incentive plans.
NYSE
TransUnion will hold its 2024 Annual Meeting of Stockholders virtually on May 2, 2024, to vote on director elections, auditor ratification, executive compensation, and amendments to stock incentive plans.
Worse than expected

Schedule 13G - Passive Investments

See all →
NYSE
Massachusetts Financial Services Company has updated its beneficial ownership filing for TransUnion, now holding 5.6% of the company's common stock.
NYSE
FMR LLC has filed a Schedule 13G, disclosing beneficial ownership of 11,634,421.71 shares, representing 6.0% of TransUnion's common stock as of June 30, 2026.
NYSE
Investment firm Dodge & Cox reports a 12.1% beneficial ownership stake in TransUnion common stock.
NYSE
Massachusetts Financial Services Company reports beneficial ownership of 13,146,925 shares, representing 6.8% of TransUnion's common stock.
NYSE
Dodge & Cox has reported a significant beneficial ownership stake of 8.4% in TransUnion, holding over 16 million shares.
NYSE
Independent Franchise Partners, LLP has reported beneficial ownership of 12,131,944 shares of TransUnion common stock, representing 6.29% of the class.